Rs 1,900 Puts — Just Below Current Price — Draw 4,257 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

On 3 July 2026, Sun Pharmaceutical Industries Ltd witnessed significant put option activity at the Rs 1,900 strike for the 28 July 2026 expiry. The 4,257 contracts traded represent a sizeable turnover of approximately ₹423.29 lakhs, with open interest standing at 1,185 contracts. The ratio of contracts traded to open interest, roughly 3.6:1, indicates a substantial amount of fresh positioning rather than mere adjustments to existing positions. Meanwhile, the stock itself has been on a steady upward trajectory, gaining 2.86% over the past three days and hitting a new 52-week high of Rs 1,925.10 during intraday trading.

Sun Pharmaceutical Industries Ltd is outperforming its sector by 0.74% today and has risen 1.97% on the day, comfortably trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This strong technical positioning adds an important layer to interpreting the put activity — is this put buying a hedge against a pullback or a bearish conviction?

Strike Price Analysis: Moneyness and Intent

The Rs 1,900 strike sits just 0.75% below the current underlying price of Rs 1,914.20, placing these puts slightly out-of-the-money (OTM). This narrow distance is critical in decoding the intent behind the activity. OTM puts close to the money are often purchased as protective instruments, especially when the underlying is in an uptrend. The proximity suggests that buyers may be seeking downside protection against a potential short-term correction rather than outright bearish exposure.

Alternatively, if these puts were deeply in-the-money (ITM), it would more strongly indicate directional bearish bets or part of complex spread strategies. Conversely, if the puts were far OTM, the activity might lean towards speculative hedging or put writing. Here, the strike’s closeness to the spot price and the stock’s recent gains point towards a protective stance.

Interpreting the Put Activity: Hedging, Bearish Positioning, or Put Writing?

Put option activity can signal multiple strategies. The first possibility is directional bearish positioning, where investors buy puts anticipating a decline. However, given the stock’s recent rally and new highs, this interpretation is less convincing here. The Rs 1,900 strike is only marginally below the current price, implying a modest expected drop by expiry. For a bearish bet to pay off, the stock would need to reverse recent gains and fall below this level within the next 25 days.

The second and more plausible interpretation is hedging. Investors holding long positions in Sun Pharmaceutical Industries Ltd may be buying these puts as insurance against a short-term pullback, especially since the stock is trading above all major moving averages. This protective strategy is common when a stock has rallied sharply but delivery volumes have declined, as is the case here, where delivery volume fell 5.61% against the 5-day average on 2 July. The thinning participation could prompt investors to guard against a correction — should more investors consider similar protection?

Lastly, put writing or selling is a bullish strategy where traders collect premium betting the stock will not fall below the strike. However, the open interest of 1,185 contracts is significantly lower than the contracts traded on the day, suggesting fresh buying rather than put writing. If put writing were dominant, open interest would typically rise or remain high relative to traded volume.

Open Interest and Contracts Analysis

The ratio of contracts traded (4,257) to open interest (1,185) is approximately 3.6:1, indicating that a large portion of the activity represents new positions rather than rollovers or closing trades. This fresh positioning supports the view that investors are actively seeking downside protection or establishing new bearish bets. However, the stock’s strong technical backdrop and recent gains tilt the balance towards hedging rather than outright bearish speculation.

Moreover, the stock’s liquidity, with a traded value of around ₹6.71 crores based on 2% of the 5-day average, ensures that these options trades are meaningful and not merely sporadic or illiquid activity.

Cash Market Context: Technicals and Delivery Volumes

Sun Pharmaceutical Industries Ltd is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a strong uptrend. The stock’s recent 2.86% gain over three days and new 52-week high reinforce this positive momentum. However, delivery volumes have declined by 5.61% compared to the 5-day average, indicating that the rally may not be fully supported by strong investor participation. This divergence often prompts investors to hedge their long positions with put options to protect gains.

The Rs 1,900 strike roughly aligns with a support zone just below the current price and near the 50-day moving average, a common technical level where investors might expect a pullback to find buying interest. This alignment further supports the hedging interpretation rather than a bearish directional bet.

Fundamental and Market Capitalisation Context

Sun Pharmaceutical Industries Ltd is a large-cap company with a market capitalisation of ₹4,56,354 crores, operating in the Pharmaceuticals & Biotechnology sector. Its size and sector positioning typically attract institutional investors who often use options for hedging rather than speculative directional bets. The stock’s recent outperformance relative to its sector and the broader Sensex further supports the notion that the put activity is more likely protective than bearish.

Conclusion: Protective Hedging Most Likely

The Rs 1,900 put contracts traded in large volume on 3 July 2026 for Sun Pharmaceutical Industries Ltd are positioned just below the current price, with fresh open interest indicating new positions. The stock’s recent rally, new highs, and strong technicals suggest that this put activity is predominantly hedging by investors seeking to protect gains rather than outright bearish bets. The decline in delivery volumes adds weight to this interpretation, as it signals caution despite the rally.

While a bearish interpretation cannot be entirely ruled out, the data points more convincingly to protective positioning. Put writing appears unlikely given the open interest dynamics. Should investors consider similar hedging strategies in the current market environment?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today